🇺🇸 FDA
Patent

US 8299101

1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mGluR2-receptor modulators

granted A61KA61K31/198A61K31/444

Quick answer

US patent 8299101 (1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mGluR2-receptor modulators) held by Addex Pharma, S.A. expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Addex Pharma, S.A.
Grant date
Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/198, A61K31/444, A61P, A61P1/14